Update of a Phase I/II Trial of 5-Azacytidine Prior to Gemtuzumab Ozogamicin (GO) for Patients with Relapsed Acute Myeloid Leukemia with Correlative Biomarker Studies Ball, E. D., Medeiros, B. C., Balaian, L., Roque, T., Corringham, S., Rajwanshi, R., Coutre, S., Gotlib, J. R., Bashey, A., Messer, K. AMER SOC HEMATOLOGY. 2010: 1346

View details for Web of Science ID 000289662203617